You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 14 Next »

Project Scope

This project team will define best practices for ensuring that similar types of adverse events are considered together for purposes of safety analyses. This project will develop efficient standardised processes and analyses that can leverage new technologies.

Project LeadsEmails
Mary Nilsson 

nilsson_mary_e@lilly.com

Greg Ball gball@novavax.com
Objectives & Deliverables 
White Paper 
Journal Article 

CURRENT STATUS Q2/3 2022

New project for Q22022
Project Members Organisation 
Brian Panik MedAssessment 
Hannah Palac AbbVie 
Mac Gordon Johnson & Jhonson 
Nhi Beasley FDA
Peg Fletcher MedAssessment 
Ramaiah MuvvalaInductive Quotient
Rebeka Revis IQVIA
Scott ProestelFDA
Vaishali PopatFDA
  • No labels